COVID-19 Infection Control and Therapeutics Resources

Date Published	Source	Title/Link/Description
1/3/24	CDC	CDC Unveils the National Wastewater Surveillance Program
11/1/23	CDC	2024 Guideline to Prevent Transmission of Pathogens in Healthcare Settings
8/22/23	HHS	Project NextGen Awards Over $1.4 Billion to Develop the Future of COVID-19 Vaccines and Therapeutics
5/25/23	FDA	FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults
5/11/23	HHS	Fact Sheet: HHS Details $5 Billion ‘Project NextGen’ Initiative to Stay Ahead of COVID-19
4/4/23	FDA	FDA Authorizes Gohibic (vilobelimab) Injection for the Treatment of COVID-19
2/7/23	FDA	Frequently Asked Questions on the Emergency Use Authorization for Lagevrio (molnupiravir) for Treatment of COVID-19
1/17/23	CDC	The Respiratory Virus Hospitalization Surveillance Network
1/5/23	NIH	NIH Launches Home Test to Treat Telehealth Program
1/6/23	FDA	XBB.1.5 Cases Evade Therapeutics
12/28/22	CDC	CDC Announces Negative COVID-19 Test Requirement from Air Passengers Entering the United States from the People’s Republic of China
12/23/22	FDA	FDA Approves Actemra for Adults
9/23/22	CDC	Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic
9/22/22	CDC	CDC Strategy for Global Response to COVID-19 (2020-2023)
9/8/22	White House	Biden Administration Outlines Plan to Get Americans an Updated COVID-⁠19 Vaccine Shot and Manage COVID-⁠19 this Fall
8/19/22	CDC	Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems
8/2/22	HHS	Information Sheet – Paxlovid Eligibility and Effectiveness
8/2/22	HHS	National Research Action Plan on Long COVID-19
8/2/22	HHS	Services and Supports for Longer-Term Impacts of COVID-19
5/24/22	CDC	Study: Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years
5/24/22	CDC	COVID-19 Rebound After Paxlovid Treatment
5/10/22	FDA	Approval of a new indication for Olumiant (baricitinib) for the treatment of COVID-19 in hospitalized adults requiring supplemental oxygen
4/25/22	FDA	FDA Approves First COVID-19 Treatment for Young Children
4/14/22	FDA	New Paxlovid Dose Pack Authorized by FDA
4/5/22	HHS, ASPR	Distribution of Sotrovimab Paused to All HHS Regions
3/10/22	CDC	Mask Use on Public Transportation
1/20/22	CDC	Quarantine and Isolation Guidance
12/8/21	FDA	Emergency Use Authorization of AstraZeneca’s EVUSHELD for use as pre-exposure prophylaxis of COVID-19
12/2/21	FDA	FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns
9/17/21	CDC	$2.1 Billion announced by the Biden administration to improve infection control
9/10/21	CDC	Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic
9/10/21	CDC	Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2
9/10/21	CDC	Interim Infection Prevention and Control Recommendations to Prevent SARS-CoV-2 Spread in Nursing Homes
7/30/21	FDA	FDA Permits Use of REGEN-COV for Post-Exposure Prophylaxis of COVID-19
7/27/21	CDC	Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage
7/26/21	HHS, DOJ	Guidance on “Long COVID” and Disability Rights
6/30/21	HHS	COVID-19 Monoclonal Antibody Therapeutics Calculator for Infusion Sites
6/24/21	FDA	Fact Sheet for Healthcare Providers: Emergency Use Authorization for Actemra
6/17/21	HHS	Biden Administration to Invest $3 Billion from American Rescue Plan as Part of COVID-19 Antiviral Development Strategy
6/14/21	CDC	Evaluating and Caring for Patients with Post-COVID Conditions: Interim Guidance
5/27/21	HHS	COVID-19 Guidance for Hospital Reporting and FAQs For Hospitals, Hospital Laboratory, and Acute Care Facility Data Reporting (Updated)
5/26/21	ASPR, FDA	Certain States Pause Distribution of Bamlanivimab and Estesebimab Together
5/14/21	FDA	Fact Sheet for Health Care Providers on the Emergency Use Authorization of bamlanivimab and etesevimab
5/13/21	CMS	Updated Interim Public Health Recommendations for Fully Vaccinated People
5/13/21	CMS	Interim Final Rule: Vaccine Requirements for Long-Term Care (LTC) Facilities
5/6/21	CMS	CMS Increases Medicare Payment for COVID-19 Monoclonal Antibody Infusions
4/27/21	CDC	Interim Public Health Recommendations for Fully Vaccinated People
4/27/21	CDC	Updated Healthcare Infection Prevention and Control Recommendations in Response to COVID-19 Vaccination
4/16/21	FDA	FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab
4/13/21	NIH	Trial of anti-CD14 antibody to treat COVID-19 respiratory disease begins
3/18/21	FDA	Updated health care provider fact sheets – monoclonal antibody therapies
3/17/21	HHS	Biden Administration to Invest $150 Million to Expand Access to COVID-19 Treatments in Underserved Communities
3/16/21	FDA	Screening for COVID-19: Deciding Which Test to Use When Establishing Testing Programs
3/10/21	CDC	Updated Healthcare Infection Prevention and Control Recommendations in Response to COVID-19 Vaccination
3/8/21	CDC	Interim Public Health Recommendations for Fully Vaccinated People
2/10/21	CDC	CDC Study: Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure
2/9/21	FDA	FDA Authorizes Eli Lilly Monoclonal Antibodies for Treatment of COVID-19: Bamlanivimab and Etesevimab Administered Together
2/8/21	CMS	CMS Extends Deadlines for Submitting HCAHPS and Interoperability Data
1/28/21	CDC	Requirement for Proof of Negative COVID-19 Test or Recovery from COVID-19 for All Air Passengers Arriving in the United States
1/12/21	HHS	Updated Hospital Reporting and FAQs For Hospitals, Hospital Laboratory, and Acute Care Facility Data Reporting
1/7/21	CDC	New COVID-19 Variants, Variant Cases
11/24/20	FDA	FDA Webpage with FAQs About Face Masks, Surgical Masks, and Respirators for COVID-19
11/21/20	FDA	FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 (Regeneron)
11/19/20	FDA	FDA Authorizes Drug Combination for Treatment of COVID-19
11/17/20	FDA	COVID-19 Update: FDA’s Ongoing Commitment to Transparency for COVID-19 EUAs
11/10/20	CMS	Medicare Monoclonal Antibody COVID-19 Infusion Program Instruction
11/10/20	Eli Lilly, FDA	Fact Sheet for Health Care Providers Emergency Use Authorization of Bamlanivimab
11/10/20	Eli Lilly	Lilly Bamlanivimab Antibody Playbook
11/10/20	FDA	Emergency Use Authorization (EUA) for emergency use of bamlanivimab
11/10/20	HHS, DoD	OWS Therapeutics: Monoclonal Antibody Playbook (updated)
11/9/20	FDA	Frequently Asked Questions on the Emergency Use Authorization for Bamlanivimab
11/9/20	NIH	Hydroxychloroquine does not benefit adults hospitalized with COVID-19
11/4/20	CDC	Updated Interim Infection Prevention and Control Recommendations for Healthcare Personnel During COVID-19 Pandemic
11/4/20	HHS, DoD	Update: Allocation and distribution of Operation Warp Speed Therapeutics
11/2/20	HHS, DoD	DRAFT Operation Warp Speed Therapeutics Pre-EUA Playbook – Monoclonal Antibodies (Outpatient administration playbook)
10/29/20	CDC	Wear Face Masks on Public Transportation Conveyances and at Transportation Hubs
10/22/20	FDA	FDA approves antiviral drug Veklury (remdesivir)
10/21/20	CDC	COVID-19 in a Correctional Facility Employee Following Multiple Brief Exposures to Persons with COVID-19
10/21/20	CDC	CDC updates definition of “close contact”
10/13/20	NIH	Study to Identify Promising COVID-19 Treatments for Larger Clinical Trials
10/6/20	FDA	FDA Briefing Document, Vaccines and Related Biological Products Advisory Committee Meeting (October 22, 2020): Development, authorization and licensure of vaccines to prevent COVID-19
10/5/20	CDC	How COVID-19 Spreads
10/1/20	HHS	Remdesivir Now Available Directly from Distributor
9/1/20	FDA	Stop Using Gowns, including Surgical Gowns, from Laws of Motion PPE – Letter to Health Care Providers
8/28/20	FDA	FDA Broadens EUA for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19
8/24/20	CDC	Updated Guidance for SARS-CoV-2 (COVID-19) Testing
8/23/20	FDA	Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment
8/5/20	FDA	Umbrella EUA for Surgical Masks
7/30/20	FDA	Updated FAQs on the EUA for Remdesivir for Certain Hospitalized COVID-19 Patients
7/30/20	CMS, CDC	Provider reimbursement available for counseling patients to self-isolate at time of COVID-19 testing
7/28/20	CMS	COVID-19 Counseling Check List
7/18/20	CDC	How to Report COVID-19 Laboratory Data
7/17/20	CDC	Updated Interim Guidance, Criteria for Return to Work for Healthcare Personnel with SARS-CoV-2 Infection
7/17/20	CDC	Updated Interim Guidance, Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings
7/17/20	CDC	Duration of Isolation and Precautions for Adults with COVID-19 (Decision Memo)
6/28/20	CDC	Considerations for Wearing Cloth Face Coverings
6/25/20	CDC	People Who Need Extra Precautions: People of Any Age with Underlying Medical Conditions
4/30/20	CDC	Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings
4/30/20	CDC	Updated Criteria for Return to Work for Healthcare Personnel with Confirmed or Suspected COVID-19Criteria for Return to Work for Healthcare Personnel with Confirmed or Suspected COVID-19
4/13/20	CDC	Updated Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Healthcare Settings
4/8/20	CDC	Updated guidance for critical infrastructure workers’ return to work following exposure to COVID-19
4/8/20	CMS	Updated Infection Control Guidance for Inpatient and Outpatient Settings
3/31/20	FEMA	Coronavirus (COVID-19) Pandemic: Non-Congregate Sheltering
3/30/20	HHS	Secretary Azar Statement on FDA Authorization of Mask Sterilization Procedure
3/29/20	FDA	Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
3/29/20	FDA	Emergency Use Authorization for the Emergency Used of the Battelle CCDS Critical Care Decontamination System
3/26/20	FDA	Q&A for Consumers: Hand Sanitizers and COVID-19
3/23/20	CMS	CMS Announces Findings at Kirkland Nursing Home and New Targeted Plan for Healthcare Facility Inspections in Light of COVID-19
3/20/20	CMS	Minimizing Face-to-Face Contact for Medication Delivery or Dispensing
3/17/20	CMS	Information for PACE Organizations Regarding Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19)
3/16/20	White House	Coronavirus Guidelines for America
3/13/20	CMS	Guidance for Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19) in Nursing Homes-REVISED
3/11/20	FDA	Surgical Mask and Gown Conservation Strategies – Letter to Healthcare Providers
3/10/20	CMS	Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) in Dialysis Facilities
3/10/20	CMS	Guidance for Use of Certain Industrial Respirators by Health Care Personnel
3/10/20	CMS	Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) in Home Health Agencies (HHAs)
3/10/20	CMS	CMS Issues Key Protective Mask Guidance for Healthcare Workers
3/10/20	CMS	CMS Sends More Detailed Guidance to Providers about COVID-19
3/9/20	CMS	Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) by Hospice Agencies
3/9/20	CMS	CMS Issues Clear, Actionable Guidance to Providers about COVID-19 Virus
3/4/20	CMS	Guidance for Infection Control and Prevention Concerning Coronavirus Disease (COVID-19): FAQs and Considerations for Patient Triage, Placement and Hospital Discharge
3/4/20	CMS	CMS Announces Actions to Address Spread of Coronavirus

Statement:

America’s Essential Hospitals Commends Congress for Passing Government Funding Package

COVID-19 Infection Control and Therapeutics Resources